Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $550.4K | $5.7M | $35.6M | $50.7M | $28.8M | $30.2M | $32.5M | $28.0M |
| Cost of revenue | $3.2M | $9.7M | $21.3M | $26.3M | $29.9M | $36.4M | $42.5M | $29.1M |
| Gross profit | −$2.7M | −$4.0M | $14.3M | $24.4M | −$1.1M | −$6.1M | −$10.0M | −$1.1M |
| Gross margin | -487.4% | -69.2% | 40.1% | 48.1% | -3.9% | -20.3% | -30.9% | -3.9% |
| R&D | $0 | $0 | $384.0K | $2.3M | $2.6M | $6.3M | $4.8M | $2.9M |
| Operating income | −$9.6M | −$11.2M | $3.1M | $10.9M | −$13.8M | −$22.3M | −$24.5M | −$15.0M |
| EBITDA | −$9.2M | −$10.9M | $5.9M | $13.0M | −$4.6M | −$15.3M | −$20.9M | −$38.3M |
| Net income | −$8.6M | −$8.6M | $6.0M | $13.2M | −$7.0M | −$14.7M | −$39.9M | −$44.3M |
| Net margin | -1571.4% | -150.7% | 16.9% | 25.9% | -24.3% | -48.5% | -122.8% | -158.5% |
| EPS (diluted) | -0.03 | -0.03 | 0.02 | 0.04 | -0.02 | -0.04 | -0.12 | -0.12 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds EOFBY.
No tracked institution reports a position in EOFBY as of their last filing.
No one on the platform has traded EOFBY yet.
| $76M |
| — |
| GDNSFGoodness Growth Holdings, Inc. | $0.45 | — | $61M | — |
| INNPFINNOCAN PHARMA Corp | $1.70 | -10.53% | $8M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.